Yangmei, Taiwan

Li-Ta Kao

This inventor holds 7 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Chirogate International Inc.. Active years: 2015-2020.

USPTO Granted Patents = 7 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 4

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2015-2020

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Inventor Li-Ta Kao**

Introduction

Li-Ta Kao is a prominent inventor based in Yangmei, Taiwan, with a remarkable portfolio comprising seven patents. His innovative work primarily focuses on the development of processes and intermediates for the preparation of isomer-free prostaglandins, which have significant applications in various fields, including pharmaceuticals and biotechnology.

Latest Patents

Among his latest patents, Li-Ta Kao has contributed to groundbreaking processes that enable the preparation of a compound of Formula I-2, notably free of the 5,6-trans isomer. This innovation is essential for producing high-purity prostaglandins and their derivatives. The detailed specifications of these patents highlight the novel intermediates and processes that enhance the efficiency and effectiveness of synthesizing isomer-free compounds.

Career Highlights

Li-Ta Kao currently works at Chirogate International Inc., a company renowned for its focus on innovative solutions in the pharmaceutical industry. His patents not only reflect his technical expertise but also contribute to the advancement of healthcare technologies. Over the years, his dedication to research and innovation has established him as a leader in his field.

Collaborations

Collaboration plays a vital role in Li-Ta Kao's career. He has worked alongside talented colleagues, including Shih-Yi Wei and Yu-Chih Yeh. These partnerships have fostered a creative environment conducive to the development of innovative solutions and have enhanced the potential of their collective contributions to the industry.

Conclusion

Li-Ta Kao’s innovative efforts and ongoing research are crucial in advancing the field of prostaglandin preparations. With a strong patent portfolio and collaborative spirit, he continues to make significant strides in the realm of pharmaceuticals, demonstrating the impact of dedicated inventors in shaping the future of healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…